Is Summit Therapeutics a Millionaire Maker?
Multiple paths to immense wealth exist. A few lucky people win the lottery. Some start successful businesses. Others invest in stocks that deliver explosive gains.
Summit Therapeutics (NASDAQ: SMMT) is one of those stocks that have been quite explosive: The share price of the clinical-stage drugmaker has skyrocketed by nearly 390% over the last 12 months. But is Summit Therapeutics a millionaire-maker?
We can explain Summit Therapeutics' remarkable stock performance with just one word: ivonescimab. That's the cancer drug Summit licensed from Chinese drugmaker Akeso (OTC: AKES.F) in 2022.
Source Fool.com
